Kwaliteitsstandaard atypische parkinsonismen

Pagina 244 O VERIGE GERAADPLEEGDE LITERATUUR Aanvullend gebruikte literatuur KS Atypische Parkinsonismen - Asseldonk e.a.; Richtlijn diëtetiek bij de ziekte van Parkinson - Abbott S, Videnovic A. Sleep disorders in atypical parkinsonism. Mov Disord Clin Pract (Hoboken) 2014;1:89-96. - Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patiënts with Parkinson's disease: a randomised, double ‐ blind, placebo ‐ controlled trial. Lancet Neurol. Jun 2010;9(6):573 ‐ 580. - Barsottini, O., Felício, A., de Aquino, C., Pedroso, J. Progressive supranuclear palsy. New concepts. Arq Neuropsiquiatr 2010;68(6):938-946 - Benamer, H. Parkinsonism and tremor disorders. A clinical approach. Libyan J Med, 2007, AOP: 061222 - Benamer H, Grosset D. Vascular parkinsonism: a clinical review. Eur Neurol 2009;61:11-15. - Bohlhalter S, Kagi G. Parkinsonism: heterogeneity of a common neurological syndrome. Swiss Med Wkly 2011;141:w13293. - Boxer, A., Yu, J., Golbe, L., Litvan, I. et al. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 2017; 16: 552–63 - Broski S, Hunt C, Johnson G, Morreale R, Lowe V, Peller P. Structural and functional imaging in parkinsonian syndromes. RadioGraphics 2014;34:1273-1292. - Brown R, Lockwood A, Sonawane B. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005;113:1250-1256. - Burn, D., Jaros, E. Multiple system atrophy: cellular and molecular pathology. J Clin Pathol: Mol Pathol 2001; 54 :419–426 - Burn D, Emre M, McKeith I, et al. Effects of rivastigmine in patiënts with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord. Nov 006;21(11):1899 ‐ 1907. - Cardoso Vale T, Caramelli P, Cardoso F. Vascular parkinsonism: a series of 17 cases. Arq Neuropsiquiatr 2013;71:757-762. - Castellani, R. Multiple System Atrophy. Clues from Inclusions. American Journal of Pathology, Vol. 153, No. 3, September 1998 - Choi, S., Kim, B., Nam, T., Kim, J. et al. Midbrain Atrophy in Vascular Parkinsonism. Eur Neurol 2011;65:296–301 - Chu, Y., Kordower, J. The Prion Hypothesis of Parkinson’s Disease. Curr Neurol Neurosci Rep (2015) 15: 28 DOI 10.1007/s11910-015-0549-x - Clavaguera, F., Lavenir, I., Falcon, B., Frank, S. et al. Mini - symposium: “ Prion-like” templated misfolding in tauopathies. Brain Pathology 23 (2013) 342–349 - Colosimo C, Bak T, Bologna M, Berardelli A. Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2014;85:936-942. - Cumming K , Macleod A D, Myint PK, Counsell CE. Early weight loss in parkinsonism predicts poor outcomes. Evidence from an incident cohort study . Neurology. 2017 Nov 28; 89(22): 2254–2261. - Cumming; Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study, 2017 - Damon-Perriere N, Foubert-Samier A, De Cock VC, Gerdelat-Mas A, Debs R, Pavy-Le Traon A, et al. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: Relation to UMSARS scores and progression over time. Parkinsonism Relat Disord 2012;18(5):612-5. - Dickson, D. Parkinson’s Disease and Parkinsonism: Neuropathology. Cold Spring Harb Perspect Med 2012;2:a009258 - Donker Kaat L, Boon A, Heutink P, van Swieten J. Progressieve supranucleaire verlamming; een bijzondere vorm van parkinsonisme. Ned Tijdschr Geneeskd 2004;148:519-523.